healthcare news Glenmark Launches Glempa Range to Combat Diabetes and Heart Disease Glenmark introduces Glempa, a new range of Empagliflozin-based medications to manage type 2 diabetes and cardiovascular risks, offering flexible treatment options for better health outcomes.
News Glenmark Pharmaceuticals, Ichnos Sciences Unveil Ichnos Glenmark Innovation (IGI) for Advanced Cancer Treatment Research Glenmark Pharmaceuticals and Ichnos Sciences unite to launch Ichnos Glenmark Innovation (IGI), a revolutionary alliance dedicated to accelerating new drug discovery in cancer treatment.
